News

TipRanks on MSN2d
Why Is Calidi Biotherapeutics Stock (CLDI) Up 170% Today?
Calidi Biotherapeutics stock was up 171.84% in pre-market trading on Wednesday, following a 39.47% rally yesterday. However, ...
Benzinga.com3d
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Calidi Biotherapeutics Inc. CLDI stock surged by 39.47% in the after-hours trading session on Tuesday. The stock price ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $4.6 Million Through Warrant Exercise Agreement
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...
Morningstar2d
Calidi Biotherapeutics Inc. (NYSE American: CLDI ... - Morningstar
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW ...
TMCnet2d
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
Ladenburg Thalmann & Co, Inc. is acting as the exclusive placement agent for the offering.
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Morningstar2d
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million ...
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the ...